Aditxt, Inc.
8-K
June 1, 2026
Key Highlights
- Strategic pivot toward accelerated commercialization of cancer diagnostics.
- Appointment of Jeffrey M. Busch as Interim CEO to drive operational efficiency.
- Consolidation of leadership under the Ignite Proteomics platform.
Read Analysis
π€ AI Generated